Continuous Treatment Study of Topiramate in Migraine Participants
- First Posted Date
- 2013-02-27
- Last Posted Date
- 2013-05-31
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 296
- Registration Number
- NCT01799590
A Study to Evaluate the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Patients With Recurrent Mature B-Cell Neoplasms
- First Posted Date
- 2012-10-12
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 15
- Registration Number
- NCT01704963
A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-09-21
- Last Posted Date
- 2016-10-27
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 122
- Registration Number
- NCT01689532
A Study to Evaluate the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic Disorder
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-06-21
- Last Posted Date
- 2015-10-15
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 39
- Registration Number
- NCT01624675
A Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With Schizophrenia
- First Posted Date
- 2012-05-25
- Last Posted Date
- 2013-06-05
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 56
- Registration Number
- NCT01606254
A Long-Term Study of JNS007ER in Patients With Schizophrenia
- First Posted Date
- 2012-03-23
- Last Posted Date
- 2012-09-28
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 228
- Registration Number
- NCT01561898
A Study of JNJ-39758979 in Adult Japanese Patients With Moderate Atopic Dermatitis
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2011-12-22
- Last Posted Date
- 2015-12-02
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 88
- Registration Number
- NCT01497119
A Study to Evaluate Skin Irritation and Photo Irritation of JNJ 10229570-AAA on Intact Skin of Japanese Healthy Male Participants
- First Posted Date
- 2011-12-19
- Last Posted Date
- 2012-10-31
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 30
- Registration Number
- NCT01494714
A Study of JNS020QD in Patients With Chronic Pain
- First Posted Date
- 2011-12-15
- Last Posted Date
- 2014-03-24
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 77
- Registration Number
- NCT01493245
A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-12-15
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 18
- Registration Number
- NCT01492647
© Copyright 2024. All Rights Reserved by MedPath